- Use of exogenous hormones in those at increased risk for breast cancer: contraceptive and menopausal hormones in gene carriers and other high-risk patients.
- Pederson HJ, Batur P.
- Menopause. 2023 Jan 10. doi: 10.1097/GME.0000000000002136. Epub ahead of print.
- PMID: 36626703
- PubMed abstract
- Source abstract
- Review
- January 2023: Awareness of genetic testing – results and analysis from the 2020 Health Information National Trends Survey.
- Mechanic L, Helzlsouer K.
- Genet Med. GenePOD. 2023 Jan 9.
- Podcast
- Free Audio
•• Original research:
Awareness and use of genetic testing: An analysis of the Health Information National Trends Survey 2020.
- PMID: 36136089
- PubMed abstract
- Free Full Texts
- Genetic Testing in the Latinx community: Impact of acculturation and provider relationships.
- Ioffe YJ, Hong L, Joachim-Célestin M, Soret C, Montgomery S, Unternaehrer JJ.
- Gynecol Oncol. 2022 Dec 26;169:125-130. doi: 10.1016/j.ygyno.2022.12.001. Epub ahead of print.
- PMID: 36577267
- PubMed abstract
- Source abstract
- Sociodemographic, Clinical, and Variation Outcomes for Breast Cancer and Breast Cancer-Related Mutations in a Ten-Year Cohort From Neiva, Huila, Colombia.
- Olaya J, Sanjuan J, Torres-Lopez D, Olaya L, Gutierrez-Vargas M, Olaya G, Olaya JD.
- Cureus. 2022 Dec 6;14(12):e32257. doi: 10.7759/cureus.32257.
- PMID: 36620844
- PubMed abstract